{"id": "article-29964_0", "title": "Testicular Teratoma -- Continuing Education Activity", "content": "Testicular teratoma is a neoplasm derived from germ cells of the testicle. It can display diverse biological behavior with an aggressive nature at times, and therefore it must be promptly diagnosed and treated. This activity reviews the evaluation and treatment of testicular teratoma and highlights the interprofessional team's role in evaluating and treating patients with this condition.", "contents": "Testicular Teratoma -- Continuing Education Activity. Testicular teratoma is a neoplasm derived from germ cells of the testicle. It can display diverse biological behavior with an aggressive nature at times, and therefore it must be promptly diagnosed and treated. This activity reviews the evaluation and treatment of testicular teratoma and highlights the interprofessional team's role in evaluating and treating patients with this condition."}
{"id": "article-29964_1", "title": "Testicular Teratoma -- Continuing Education Activity", "content": "Objectives: Identify the etiology of testicular teratoma and emergencies associated with it. Review the investigation of testicular teratoma. Outline the management options available for testicular teratoma. Identify some interprofessional team strategies that can result in better care coordination for patients presenting with testicular teratoma. Access free multiple choice questions on this topic.", "contents": "Testicular Teratoma -- Continuing Education Activity. Objectives: Identify the etiology of testicular teratoma and emergencies associated with it. Review the investigation of testicular teratoma. Outline the management options available for testicular teratoma. Identify some interprofessional team strategies that can result in better care coordination for patients presenting with testicular teratoma. Access free multiple choice questions on this topic."}
{"id": "article-29964_2", "title": "Testicular Teratoma -- Introduction", "content": "Testicular teratoma is a germ cell-derived neoplasia composed of different somatic tissues and can be derived from one or more germinal layers (endoderm,\u00a0mesoderm, and ectoderm). According to the WHO classification, germ cell tumors of the testis are divided into\u00a0two main groups: [1] Germ cell neoplasms comprise germ cell neoplasia in situ\u00a0(GCNIS), seminoma, and non-seminoma (NSGCT). The latter encompasses teratoma (postpubertal type), embryonal carcinoma, choriocarcinoma, yolk sac tumors (YSTs). non-GCNIS tumors include spermatocytic tumors,\u00a0YST prepubertal type, teratoma (prepubertal type).", "contents": "Testicular Teratoma -- Introduction. Testicular teratoma is a germ cell-derived neoplasia composed of different somatic tissues and can be derived from one or more germinal layers (endoderm,\u00a0mesoderm, and ectoderm). According to the WHO classification, germ cell tumors of the testis are divided into\u00a0two main groups: [1] Germ cell neoplasms comprise germ cell neoplasia in situ\u00a0(GCNIS), seminoma, and non-seminoma (NSGCT). The latter encompasses teratoma (postpubertal type), embryonal carcinoma, choriocarcinoma, yolk sac tumors (YSTs). non-GCNIS tumors include spermatocytic tumors,\u00a0YST prepubertal type, teratoma (prepubertal type)."}
{"id": "article-29964_3", "title": "Testicular Teratoma -- Introduction", "content": "The vast majority of adult testicular teratomas are malignant germ cell tumors.\u00a0Teratoma\u00a0accounts for about 3\u00a0to 7% of NSGCT and about 50% of mixed GCTs. As stated in the WHO classification (2016), two types of testicular teratomas exist: Prepubertal teratoma is considered an indolent tumor and is not associated with germ cell neoplasia in situ;\u00a0the testis shows normal spermatogenesis and has no metastatic\u00a0potential. This histotype is not specific to children and can be found in adult patients. This group includes dermoid or epidermoid cysts. Postpubertal teratoma is GCNIS-derived\u00a0and has metastatic potential\u00a0(metastasizes in 22% to 37% of cases).", "contents": "Testicular Teratoma -- Introduction. The vast majority of adult testicular teratomas are malignant germ cell tumors.\u00a0Teratoma\u00a0accounts for about 3\u00a0to 7% of NSGCT and about 50% of mixed GCTs. As stated in the WHO classification (2016), two types of testicular teratomas exist: Prepubertal teratoma is considered an indolent tumor and is not associated with germ cell neoplasia in situ;\u00a0the testis shows normal spermatogenesis and has no metastatic\u00a0potential. This histotype is not specific to children and can be found in adult patients. This group includes dermoid or epidermoid cysts. Postpubertal teratoma is GCNIS-derived\u00a0and has metastatic potential\u00a0(metastasizes in 22% to 37% of cases)."}
{"id": "article-29964_4", "title": "Testicular Teratoma -- Introduction", "content": "A rare encounter is a teratoma with somatic-type transformation, defined as \u201cteratoma that develops a distinct secondary component that resembles a somatic-type malignant neoplasm,\" which\u00a0has specific prognosis and treatment and needs to be distinguished from postpubertal teratomas.", "contents": "Testicular Teratoma -- Introduction. A rare encounter is a teratoma with somatic-type transformation, defined as \u201cteratoma that develops a distinct secondary component that resembles a somatic-type malignant neoplasm,\" which\u00a0has specific prognosis and treatment and needs to be distinguished from postpubertal teratomas."}
{"id": "article-29964_5", "title": "Testicular Teratoma -- Introduction", "content": "The outcomes for patients with localized disease are good, and they are candidates for surgical therapy. Patients with metastatic disease have a poorer outcome that depends on several clinical and pathological factors and are treated in a multimodal approach involving different medical professionals. Metastatic tumors do not respond well to chemotherapy, and the goal is to achieve a complete surgical resection.", "contents": "Testicular Teratoma -- Introduction. The outcomes for patients with localized disease are good, and they are candidates for surgical therapy. Patients with metastatic disease have a poorer outcome that depends on several clinical and pathological factors and are treated in a multimodal approach involving different medical professionals. Metastatic tumors do not respond well to chemotherapy, and the goal is to achieve a complete surgical resection."}
{"id": "article-29964_6", "title": "Testicular Teratoma -- Etiology", "content": "As previously described, according to WHO, one of the main changes is the division into postpubertal-type teratoma and prepubertal-type teratoma.\u00a0Postpubertal type\u00a0is considered as differentiation from other germ cell tumor types. Therefore, this specific type of teratoma can be associated with\u00a0GCNIS and may develop metastases resembling the primary\u00a0teratoma or other germ cell tumors.", "contents": "Testicular Teratoma -- Etiology. As previously described, according to WHO, one of the main changes is the division into postpubertal-type teratoma and prepubertal-type teratoma.\u00a0Postpubertal type\u00a0is considered as differentiation from other germ cell tumor types. Therefore, this specific type of teratoma can be associated with\u00a0GCNIS and may develop metastases resembling the primary\u00a0teratoma or other germ cell tumors."}
{"id": "article-29964_7", "title": "Testicular Teratoma -- Etiology", "content": "Germ cell tumors (GCT)\u00a0originate from a primordial germ cell that can differentiate into ectoderm, mesoderm, and endoderm, thereby giving rise to a\u00a0mixture of somatic cell\u00a0tissues that characterize teratoma.\u00a0Gains in chromosome 12p and expression of IMP3 are\u00a0common in GCT. [2] [3]", "contents": "Testicular Teratoma -- Etiology. Germ cell tumors (GCT)\u00a0originate from a primordial germ cell that can differentiate into ectoderm, mesoderm, and endoderm, thereby giving rise to a\u00a0mixture of somatic cell\u00a0tissues that characterize teratoma.\u00a0Gains in chromosome 12p and expression of IMP3 are\u00a0common in GCT. [2] [3]"}
{"id": "article-29964_8", "title": "Testicular Teratoma -- Etiology -- Prenatal Risk Factors", "content": "There are recognized risk factors in developing germ cell tumors, mainly\u00a0intrauterine growth retardation (low birth weight and newborns\u00a0small for gestational age),\u00a0cryptorchidism, hypospadias, maternal bleeding, advanced maternal age, jaundice, and retained placenta.", "contents": "Testicular Teratoma -- Etiology -- Prenatal Risk Factors. There are recognized risk factors in developing germ cell tumors, mainly\u00a0intrauterine growth retardation (low birth weight and newborns\u00a0small for gestational age),\u00a0cryptorchidism, hypospadias, maternal bleeding, advanced maternal age, jaundice, and retained placenta."}
{"id": "article-29964_9", "title": "Testicular Teratoma -- Etiology -- Cryptorchidism", "content": "Cryptorchidism is strongly\u00a0associated with an\u00a0increased risk of\u00a0about 3-5 fold, and in a recent study, it is considered as high as 8 fold. [4] Subfertile and infertile men\u00a0bear\u00a0an increased risk of developing testicular cancer. In-utero exposure to exogenous and endogenous factors is still a matter of debate, and no international consensus has been met. Synthetic estrogen exposure (diethylstilboestrol) has been linked in some cases to\u00a0cryptorchidism and, therefore, an increased risk of testicular cancer (about twofold). [5] Children whose mothers smoked during pregnancy had a 1.18 times higher risk of cryptorchidism as compared to\u00a0controls. [6] [7] [8]", "contents": "Testicular Teratoma -- Etiology -- Cryptorchidism. Cryptorchidism is strongly\u00a0associated with an\u00a0increased risk of\u00a0about 3-5 fold, and in a recent study, it is considered as high as 8 fold. [4] Subfertile and infertile men\u00a0bear\u00a0an increased risk of developing testicular cancer. In-utero exposure to exogenous and endogenous factors is still a matter of debate, and no international consensus has been met. Synthetic estrogen exposure (diethylstilboestrol) has been linked in some cases to\u00a0cryptorchidism and, therefore, an increased risk of testicular cancer (about twofold). [5] Children whose mothers smoked during pregnancy had a 1.18 times higher risk of cryptorchidism as compared to\u00a0controls. [6] [7] [8]"}
{"id": "article-29964_10", "title": "Testicular Teratoma -- Etiology -- Past History", "content": "A personal history of GCT in the contralateral testis is the most important risk factor for developing a testicular tumor in the future.Also, pelvic irradiation is an important risk factor for the development of a testicular tumor.", "contents": "Testicular Teratoma -- Etiology -- Past History. A personal history of GCT in the contralateral testis is the most important risk factor for developing a testicular tumor in the future.Also, pelvic irradiation is an important risk factor for the development of a testicular tumor."}
{"id": "article-29964_11", "title": "Testicular Teratoma -- Etiology -- Genetic Predisposition", "content": "A family history of testicular cancer increases the relative risk of developing a similar tumor, with a fourfold rise of the risk in brothers. Nevertheless, the US Preventive Services Task Force recommends against\u00a0a screening, with a Grade D recommendation. [9] [10]", "contents": "Testicular Teratoma -- Etiology -- Genetic Predisposition. A family history of testicular cancer increases the relative risk of developing a similar tumor, with a fourfold rise of the risk in brothers. Nevertheless, the US Preventive Services Task Force recommends against\u00a0a screening, with a Grade D recommendation. [9] [10]"}
{"id": "article-29964_12", "title": "Testicular Teratoma -- Epidemiology", "content": "Testicular cancer is the most common solid tumor between the ages of 20\u00a0to 35 years.\u00a0Testicular germ cell tumors (GCTs) are by far the most common malignant group of tumors arising in the testis (95%), mainly represented by seminoma. Non-seminomatous histotypes (embryonal carcinoma, choriocarcinoma, yolk sac tumor, teratoma) are less common, more aggressive in behavior, and can be pure or mixed.", "contents": "Testicular Teratoma -- Epidemiology. Testicular cancer is the most common solid tumor between the ages of 20\u00a0to 35 years.\u00a0Testicular germ cell tumors (GCTs) are by far the most common malignant group of tumors arising in the testis (95%), mainly represented by seminoma. Non-seminomatous histotypes (embryonal carcinoma, choriocarcinoma, yolk sac tumor, teratoma) are less common, more aggressive in behavior, and can be pure or mixed."}
{"id": "article-29964_13", "title": "Testicular Teratoma -- Epidemiology", "content": "Testicular teratoma can be found in children and young adults (20\u00a0to 35 is the most common age group, as stated previously). In\u00a0children, it usually occurs in the first 2 years of life (mean age 20 months), representing the second most common GCT histotype\u00a0after yolk sac tumor.\u00a0It is rare in young adults as a pure form but is\u00a0commonly encountered in a mixed form with other GCT histotypes.", "contents": "Testicular Teratoma -- Epidemiology. Testicular teratoma can be found in children and young adults (20\u00a0to 35 is the most common age group, as stated previously). In\u00a0children, it usually occurs in the first 2 years of life (mean age 20 months), representing the second most common GCT histotype\u00a0after yolk sac tumor.\u00a0It is rare in young adults as a pure form but is\u00a0commonly encountered in a mixed form with other GCT histotypes."}
{"id": "article-29964_14", "title": "Testicular Teratoma -- Epidemiology", "content": "Of all testicular cancer, nearly 90% present with locoregional disease. In general, testicular cancer is a highly curable disease with a 5-year survival rate of 95% (based on SEER 2010\u20132016), but data change when histotype-specific survival is taken into account.\u00a0The presence of teratoma is associated with a higher\u00a0cumulative incidence of disease-related death. [11] In the IGCCCG classification, seminoma and non-seminomatous histotypes are classified separately because of the different prognostic impact of histotype. Teratoma is associated with a higher metastatic rate and treatment resistance. However, Funt et al. [12] [11] reported that 92% of deaths were associated with chemoresistant non-teratomatous GCT metastases.", "contents": "Testicular Teratoma -- Epidemiology. Of all testicular cancer, nearly 90% present with locoregional disease. In general, testicular cancer is a highly curable disease with a 5-year survival rate of 95% (based on SEER 2010\u20132016), but data change when histotype-specific survival is taken into account.\u00a0The presence of teratoma is associated with a higher\u00a0cumulative incidence of disease-related death. [11] In the IGCCCG classification, seminoma and non-seminomatous histotypes are classified separately because of the different prognostic impact of histotype. Teratoma is associated with a higher metastatic rate and treatment resistance. However, Funt et al. [12] [11] reported that 92% of deaths were associated with chemoresistant non-teratomatous GCT metastases."}
{"id": "article-29964_15", "title": "Testicular Teratoma -- Pathophysiology", "content": "The transcriptome analysis\u00a0of germ cell tumors recognized a specific genetic range of alteration, with some differences between histotypes.\u00a0Molecular studies [9] discovered a teratoma-specific gene signature. [13] [14] [15] [16] There is a high frequency of mutations in the genes related to membrane-membrane interaction, matrix formation, and remodeling enzymes in testicular teratoma. RNA transcript analysis shows enhanced production of transmembrane proteins ( CDH11, NCAM1, VCAM1, CLDN4, ITGA2, ITGB7, SDC1, SLC6A6 ), extracellular matrix-associated proteins ( CYR61, COL1A1, COL3A1, COL6A3, THBS1, LGALS4, MFAP4, MGP, SPARC, SPON1 ),\u00a0several enzymes and signaling mediators ( MMP7, SERPINA1, SERPINA3, PLA2G2A, PLAT ). [17]", "contents": "Testicular Teratoma -- Pathophysiology. The transcriptome analysis\u00a0of germ cell tumors recognized a specific genetic range of alteration, with some differences between histotypes.\u00a0Molecular studies [9] discovered a teratoma-specific gene signature. [13] [14] [15] [16] There is a high frequency of mutations in the genes related to membrane-membrane interaction, matrix formation, and remodeling enzymes in testicular teratoma. RNA transcript analysis shows enhanced production of transmembrane proteins ( CDH11, NCAM1, VCAM1, CLDN4, ITGA2, ITGB7, SDC1, SLC6A6 ), extracellular matrix-associated proteins ( CYR61, COL1A1, COL3A1, COL6A3, THBS1, LGALS4, MFAP4, MGP, SPARC, SPON1 ),\u00a0several enzymes and signaling mediators ( MMP7, SERPINA1, SERPINA3, PLA2G2A, PLAT ). [17]"}
{"id": "article-29964_16", "title": "Testicular Teratoma -- Pathophysiology", "content": "Two important genes are commonly up-regulated in teratomas ( MMP7, EGR1 ). MMP7 is a metalloproteinase involved in tissue remodeling, mainly cleaving\u00a0extracellular matrix\u00a0components and nonmatrix proteins.\u00a0EGR1 is an anti-apoptotic gene that promotes cell survival even after DNA damage. It is a possible molecular determinant of chemoresistance in teratomas. [18]", "contents": "Testicular Teratoma -- Pathophysiology. Two important genes are commonly up-regulated in teratomas ( MMP7, EGR1 ). MMP7 is a metalloproteinase involved in tissue remodeling, mainly cleaving\u00a0extracellular matrix\u00a0components and nonmatrix proteins.\u00a0EGR1 is an anti-apoptotic gene that promotes cell survival even after DNA damage. It is a possible molecular determinant of chemoresistance in teratomas. [18]"}
{"id": "article-29964_17", "title": "Testicular Teratoma -- Pathophysiology", "content": "Teratoma with malignant transformation (MT) is an entity in which a component of teratoma undergoes malignant transformation (ex. adenocarcinoma, sarcoma, etc.) that is identical to a somatic malignancy.", "contents": "Testicular Teratoma -- Pathophysiology. Teratoma with malignant transformation (MT) is an entity in which a component of teratoma undergoes malignant transformation (ex. adenocarcinoma, sarcoma, etc.) that is identical to a somatic malignancy."}
{"id": "article-29964_18", "title": "Testicular Teratoma -- Histopathology", "content": "Gross: Testicular teratoma is highly heterogeneous in appearance. The tumor is firm and usually well-circumscribed, occupying a portion or the\u00a0entirety of the testis. The cut surface can appear solid or cystic, and different heterologous elements are a common finding, such as hairs, teeth, adipose tissue, cystic mass filled with keratin or mucinous material; solid areas formed by cartilage or bone may be recognizable. Those appearances correspond to different histologic differentiation that is typical of teratoma.", "contents": "Testicular Teratoma -- Histopathology. Gross: Testicular teratoma is highly heterogeneous in appearance. The tumor is firm and usually well-circumscribed, occupying a portion or the\u00a0entirety of the testis. The cut surface can appear solid or cystic, and different heterologous elements are a common finding, such as hairs, teeth, adipose tissue, cystic mass filled with keratin or mucinous material; solid areas formed by cartilage or bone may be recognizable. Those appearances correspond to different histologic differentiation that is typical of teratoma."}
{"id": "article-29964_19", "title": "Testicular Teratoma -- Histopathology", "content": "Microscopy : Any epithelial, mesenchymal, or neural-derived tissue can be seen. Less common are tissues derived from the respiratory, gastrointestinal, or genitourinary tract. Skin-derived structures such as epithelial-derived (epidermoid cyst) or appendages is a quite common finding, especially in\u00a0prepubertal-type teratomas, while postpubertal-type teratomas tend to appear as\u00a0multiloculated cysts lined by other tissue types such as glandular epithelium and contain solid areas formed by parenchymal structure or mesenchymal tissues. A certain element of immature tissues can also be encountered, consisting of ectodermal, endodermal, or mesenchymal structures. Neuroectodermal tissue is the most common immature type and often has several differentiation stages of embryonic/fetal nervous system\u00a0tissue. Historically teratoma has been differentiated into mature and immature, but this distinction is not recommended any more due to the lack of a prognostic significance. Teratoma can occur paired with other histotypes of germ cell neoplasia, such as yolk sac tumor or embryonal carcinoma.", "contents": "Testicular Teratoma -- Histopathology. Microscopy : Any epithelial, mesenchymal, or neural-derived tissue can be seen. Less common are tissues derived from the respiratory, gastrointestinal, or genitourinary tract. Skin-derived structures such as epithelial-derived (epidermoid cyst) or appendages is a quite common finding, especially in\u00a0prepubertal-type teratomas, while postpubertal-type teratomas tend to appear as\u00a0multiloculated cysts lined by other tissue types such as glandular epithelium and contain solid areas formed by parenchymal structure or mesenchymal tissues. A certain element of immature tissues can also be encountered, consisting of ectodermal, endodermal, or mesenchymal structures. Neuroectodermal tissue is the most common immature type and often has several differentiation stages of embryonic/fetal nervous system\u00a0tissue. Historically teratoma has been differentiated into mature and immature, but this distinction is not recommended any more due to the lack of a prognostic significance. Teratoma can occur paired with other histotypes of germ cell neoplasia, such as yolk sac tumor or embryonal carcinoma."}
{"id": "article-29964_20", "title": "Testicular Teratoma -- Histopathology", "content": "Teratomatous tissue can harbor various degrees of dysplasia ranging from mild cytological atypia to obvious malignancy. For instance, glandular tissue can hide areas of in situ or invasive carcinoma, and chondroid tissue can develop chondrosarcoma. Those cases are referred to as teratoma with somatic type malignancy and can behave accordingly, developing somatic-type metastases.", "contents": "Testicular Teratoma -- Histopathology. Teratomatous tissue can harbor various degrees of dysplasia ranging from mild cytological atypia to obvious malignancy. For instance, glandular tissue can hide areas of in situ or invasive carcinoma, and chondroid tissue can develop chondrosarcoma. Those cases are referred to as teratoma with somatic type malignancy and can behave accordingly, developing somatic-type metastases."}
{"id": "article-29964_21", "title": "Testicular Teratoma -- Histopathology", "content": "Careful microscopic examination is needed to define the grade of invasion of the surrounding tissues (para-testicular) and the invasion of vascular spaces. The adjacent testicular parenchyma is usually found to be atrophic with impaired spermatogenesis; finding of germ cell neoplasia in situ (GCNIS) is common. The fibrous stroma surrounding the teratomatous tissue was thought to be a physiological response to confine the tumor, but molecular analyses found the same genetic alterations of the teratoma. Therefore even the surrounding stroma is germ cell-derived and not reactive fibrosis.", "contents": "Testicular Teratoma -- Histopathology. Careful microscopic examination is needed to define the grade of invasion of the surrounding tissues (para-testicular) and the invasion of vascular spaces. The adjacent testicular parenchyma is usually found to be atrophic with impaired spermatogenesis; finding of germ cell neoplasia in situ (GCNIS) is common. The fibrous stroma surrounding the teratomatous tissue was thought to be a physiological response to confine the tumor, but molecular analyses found the same genetic alterations of the teratoma. Therefore even the surrounding stroma is germ cell-derived and not reactive fibrosis."}
{"id": "article-29964_22", "title": "Testicular Teratoma -- Histopathology", "content": "The metastatic spread of testicular cancer\u00a0involves the para-aortic retroperitoneal lymph nodes in 95% of cases. Mesenteric lymphatics\u00a0are not a well-described metastatic pathway, but sporadic cases have been reported. [19] [20] [21] Various mechanisms of spread to the mesentery have been proposed, including direct extension and hematogenous dissemination.", "contents": "Testicular Teratoma -- Histopathology. The metastatic spread of testicular cancer\u00a0involves the para-aortic retroperitoneal lymph nodes in 95% of cases. Mesenteric lymphatics\u00a0are not a well-described metastatic pathway, but sporadic cases have been reported. [19] [20] [21] Various mechanisms of spread to the mesentery have been proposed, including direct extension and hematogenous dissemination."}
{"id": "article-29964_23", "title": "Testicular Teratoma -- Histopathology", "content": "Immunohistochemistry: Teratomatous structures express the same antigens expected for the\u00a0specific cell type. Glandular tissue is always positive for cytokeratin and epithelial membrane antigen; keratinocytes are positive for high molecular weight cytokeratins; mesenchymal tissue can express several antigens related to the mature tissue (S100 in neural-derived and adipous tissue, actin for muscular fibers, CD34 for fibroblastic cells, and so on). In mixed-type germ cell neoplasias, there might be the expression of other markers: human chorionic gonadotropin (from syncytiotrophoblastic cells), placental alkaline phosphatase, and LDH.", "contents": "Testicular Teratoma -- Histopathology. Immunohistochemistry: Teratomatous structures express the same antigens expected for the\u00a0specific cell type. Glandular tissue is always positive for cytokeratin and epithelial membrane antigen; keratinocytes are positive for high molecular weight cytokeratins; mesenchymal tissue can express several antigens related to the mature tissue (S100 in neural-derived and adipous tissue, actin for muscular fibers, CD34 for fibroblastic cells, and so on). In mixed-type germ cell neoplasias, there might be the expression of other markers: human chorionic gonadotropin (from syncytiotrophoblastic cells), placental alkaline phosphatase, and LDH."}
{"id": "article-29964_24", "title": "Testicular Teratoma -- History and Physical", "content": "Patients presenting with a\u00a0testicular mass or groin pain should be carefully evaluated. The younger age group is extremely susceptible to\u00a0testicular cancer, and young men have obvious fertility concerns regarding therapy. A detailed\u00a0history should be obtained, with information regarding undescended testis, previous testicular torsion, injury\u00a0to the groin, the growth rate of the present lesion, and the presence of any associated symptoms. A history of surgery for undescended testis is also relevant since the testis that has been brought down into the scrotum still has a 10 fold higher risk for malignant change in comparison to the normal testis. Patients can be asymptomatic or complain of painless swelling of the testicle. In other cases, patients can present with painful testicular swelling, usually due to intratumoral hemorrhage and hematoma or testicular torsion.", "contents": "Testicular Teratoma -- History and Physical. Patients presenting with a\u00a0testicular mass or groin pain should be carefully evaluated. The younger age group is extremely susceptible to\u00a0testicular cancer, and young men have obvious fertility concerns regarding therapy. A detailed\u00a0history should be obtained, with information regarding undescended testis, previous testicular torsion, injury\u00a0to the groin, the growth rate of the present lesion, and the presence of any associated symptoms. A history of surgery for undescended testis is also relevant since the testis that has been brought down into the scrotum still has a 10 fold higher risk for malignant change in comparison to the normal testis. Patients can be asymptomatic or complain of painless swelling of the testicle. In other cases, patients can present with painful testicular swelling, usually due to intratumoral hemorrhage and hematoma or testicular torsion."}
{"id": "article-29964_25", "title": "Testicular Teratoma -- History and Physical", "content": "A careful physical examination should be coupled with ultrasound\u00a0examination\u00a0and appropriate serologic studies. Bilateral tumors are uncommon; nevertheless, there should always be a comparison with the contralateral testis. An empty hemiscrotum with absent scrotal rugae would point towards undescended testis, and an associated groin swelling might indicate a malignant change in the undescended testis. Another caveat is that a fast-growing testicular cancer may feel soft due to secondary hydrocele. Still, on careful palpation, the solid mass can often be felt through the surrounding fluid. In later stages of progression, the growth incorporates the testis, and the cord structures are thickened. However, the scrotal skin is not involved until very late in the disease course. Enlarged para-aortic nodes may be palpable in a thin subject in the epigastric region. In advanced cases, the left supraclavicular lymph nodes may also be palpably enlarged (Virchow's node).", "contents": "Testicular Teratoma -- History and Physical. A careful physical examination should be coupled with ultrasound\u00a0examination\u00a0and appropriate serologic studies. Bilateral tumors are uncommon; nevertheless, there should always be a comparison with the contralateral testis. An empty hemiscrotum with absent scrotal rugae would point towards undescended testis, and an associated groin swelling might indicate a malignant change in the undescended testis. Another caveat is that a fast-growing testicular cancer may feel soft due to secondary hydrocele. Still, on careful palpation, the solid mass can often be felt through the surrounding fluid. In later stages of progression, the growth incorporates the testis, and the cord structures are thickened. However, the scrotal skin is not involved until very late in the disease course. Enlarged para-aortic nodes may be palpable in a thin subject in the epigastric region. In advanced cases, the left supraclavicular lymph nodes may also be palpably enlarged (Virchow's node)."}
{"id": "article-29964_26", "title": "Testicular Teratoma -- Evaluation", "content": "Laboratory and imaging evaluation to diagnose and stage the disease are serological tests, abdominal and retroperitoneal ultrasound, chest X-ray, CT-scan (abdominopelvic and thoracic), and in some cases MRI\u00a0or PET. [22]", "contents": "Testicular Teratoma -- Evaluation. Laboratory and imaging evaluation to diagnose and stage the disease are serological tests, abdominal and retroperitoneal ultrasound, chest X-ray, CT-scan (abdominopelvic and thoracic), and in some cases MRI\u00a0or PET. [22]"}
{"id": "article-29964_27", "title": "Testicular Teratoma -- Evaluation", "content": "Serum tumor\u00a0markers can help in the differential diagnosis of a\u00a0germ cell tumor and can be used as a baseline for follow-up.\u00a0In serum evaluation, hCG and AFP levels can be elevated. In those cases, the increased serum markers can be due to mixed histology of yolk\u00a0sac tumor and hCG-secreting syncytiotrophoblast cells.", "contents": "Testicular Teratoma -- Evaluation. Serum tumor\u00a0markers can help in the differential diagnosis of a\u00a0germ cell tumor and can be used as a baseline for follow-up.\u00a0In serum evaluation, hCG and AFP levels can be elevated. In those cases, the increased serum markers can be due to mixed histology of yolk\u00a0sac tumor and hCG-secreting syncytiotrophoblast cells."}
{"id": "article-29964_28", "title": "Testicular Teratoma -- Evaluation", "content": "Ultrasound (US) is the preferred imaging study\u00a0for evaluating testicular pathology.\u00a0It is an easy and non-invasive procedure and is highly sensitive for\u00a0identifying scrotal masses. The technique can differentiate between intratesticular and\u00a0extra-testicular lesions with a sensitivity that reaches 99%. The affected testis can be compared with the contralateral one. A normal testis has a homogeneously granular texture and is located below the\u00a0epididymis that appears iso/hyperechoic. A hydrocele would appear as extra testicular fluid in tunica vaginalis that can be easily differentiated from cystic testicular masses.", "contents": "Testicular Teratoma -- Evaluation. Ultrasound (US) is the preferred imaging study\u00a0for evaluating testicular pathology.\u00a0It is an easy and non-invasive procedure and is highly sensitive for\u00a0identifying scrotal masses. The technique can differentiate between intratesticular and\u00a0extra-testicular lesions with a sensitivity that reaches 99%. The affected testis can be compared with the contralateral one. A normal testis has a homogeneously granular texture and is located below the\u00a0epididymis that appears iso/hyperechoic. A hydrocele would appear as extra testicular fluid in tunica vaginalis that can be easily differentiated from cystic testicular masses."}
{"id": "article-29964_29", "title": "Testicular Teratoma -- Evaluation", "content": "A solid intratesticular\u00a0lesion should be\u00a0considered malignant unless proved otherwise.\u00a0The US appearance\u00a0is closely related to the gross morphology of the lesion and therefore is extremely important to carefully evaluate and describe the US images. Testicular neoplasms are usually\u00a0hypoechoic (compared to the normal parenchyma), and heterogeneity can appear if there are\u00a0calcifications and cysts.\u00a0Testicular teratoma can appear as an irregularly\u00a0solid or predominately cystic\u00a0mass.\u00a0The presence of calcifications in the tumor is another helpful finding associated with teratomas. The vascularisation\u00a0of the tumor can be evaluated with a Doppler scan, although this additional exam is\u00a0not of particular\u00a0use in the differential diagnosis.\u00a0In contrast, epididymal masses are usually\u00a0benign, but careful examination should exclude the involvement of the spermatic cord and intratesticular abnormalities.", "contents": "Testicular Teratoma -- Evaluation. A solid intratesticular\u00a0lesion should be\u00a0considered malignant unless proved otherwise.\u00a0The US appearance\u00a0is closely related to the gross morphology of the lesion and therefore is extremely important to carefully evaluate and describe the US images. Testicular neoplasms are usually\u00a0hypoechoic (compared to the normal parenchyma), and heterogeneity can appear if there are\u00a0calcifications and cysts.\u00a0Testicular teratoma can appear as an irregularly\u00a0solid or predominately cystic\u00a0mass.\u00a0The presence of calcifications in the tumor is another helpful finding associated with teratomas. The vascularisation\u00a0of the tumor can be evaluated with a Doppler scan, although this additional exam is\u00a0not of particular\u00a0use in the differential diagnosis.\u00a0In contrast, epididymal masses are usually\u00a0benign, but careful examination should exclude the involvement of the spermatic cord and intratesticular abnormalities."}
{"id": "article-29964_30", "title": "Testicular Teratoma -- Evaluation", "content": "Magnetic\u00a0resonance (MR) imaging is\u00a0not widely used in clinical practice, and its role is mainly in difficult cases and for the characterization of extra-testicular neoplasms.", "contents": "Testicular Teratoma -- Evaluation. Magnetic\u00a0resonance (MR) imaging is\u00a0not widely used in clinical practice, and its role is mainly in difficult cases and for the characterization of extra-testicular neoplasms."}
{"id": "article-29964_31", "title": "Testicular Teratoma -- Evaluation", "content": "PET scan can rarely help in the differential diagnosis as teratoma lacks the usually increased glucose uptake of tumoral tissues, i.e., it is 2-deoxy-2-fluoro-D-glucose (FDG)-negative. PET scan is not useful for differentiating teratoma and necrosis. [23]", "contents": "Testicular Teratoma -- Evaluation. PET scan can rarely help in the differential diagnosis as teratoma lacks the usually increased glucose uptake of tumoral tissues, i.e., it is 2-deoxy-2-fluoro-D-glucose (FDG)-negative. PET scan is not useful for differentiating teratoma and necrosis. [23]"}
{"id": "article-29964_32", "title": "Testicular Teratoma -- Treatment / Management", "content": "The International Germ Cell Consensus Classification\u00a0studied more than 5000 cases of non-seminomatous GCTs with metastatic spread, treated with cisplatin chemotherapy and followed for 5 years. This\u00a0provided important clinical data on metastatic cases, and in this consensus, a three-tier risk factor evaluation was created. Independent prognostic variables were identified: histotype, site of the primary tumor, tumor marker elevation (\u03b1-fetoprotein, human chorionic gonadotrophin, lactate dehydrogenase), and nonpulmonary visceral metastases.\u00a0Based on this classification, the prognosis depends on the risk class of each patient, with a mortality risk of 10%, 20% to 30%, and 50% to 60% of good-, intermediate-, and poor-risk patients, respectively. [12]", "contents": "Testicular Teratoma -- Treatment / Management. The International Germ Cell Consensus Classification\u00a0studied more than 5000 cases of non-seminomatous GCTs with metastatic spread, treated with cisplatin chemotherapy and followed for 5 years. This\u00a0provided important clinical data on metastatic cases, and in this consensus, a three-tier risk factor evaluation was created. Independent prognostic variables were identified: histotype, site of the primary tumor, tumor marker elevation (\u03b1-fetoprotein, human chorionic gonadotrophin, lactate dehydrogenase), and nonpulmonary visceral metastases.\u00a0Based on this classification, the prognosis depends on the risk class of each patient, with a mortality risk of 10%, 20% to 30%, and 50% to 60% of good-, intermediate-, and poor-risk patients, respectively. [12]"}
{"id": "article-29964_33", "title": "Testicular Teratoma -- Treatment / Management", "content": "Radical orchiectomy is the gold standard for a patient presenting with a testicular mass with clinical features concerning malignancy.\u00a0Placement of a testicular prosthesis is an aesthetic option that can\u00a0be considered before surgery. Testis-sparing surgery is only applicable for lesions that do not infiltrate the testis and are not suspicious for germ cell origin. In those cases, in fact, germ cell neoplasia in situ is often present in the surrounding parenchyma suggesting a potential to develop invasive germ cell neoplasia if left untreated. [24] Subsequent therapy depends on serum markers, histotype, vascular invasion, lymph node involvement (if a regional lymphadenectomy is performed), and the result of a CT-scan for staging purposes. For teratoma, postoperative surveillance is recommended after\u00a0orchiectomy.", "contents": "Testicular Teratoma -- Treatment / Management. Radical orchiectomy is the gold standard for a patient presenting with a testicular mass with clinical features concerning malignancy.\u00a0Placement of a testicular prosthesis is an aesthetic option that can\u00a0be considered before surgery. Testis-sparing surgery is only applicable for lesions that do not infiltrate the testis and are not suspicious for germ cell origin. In those cases, in fact, germ cell neoplasia in situ is often present in the surrounding parenchyma suggesting a potential to develop invasive germ cell neoplasia if left untreated. [24] Subsequent therapy depends on serum markers, histotype, vascular invasion, lymph node involvement (if a regional lymphadenectomy is performed), and the result of a CT-scan for staging purposes. For teratoma, postoperative surveillance is recommended after\u00a0orchiectomy."}
{"id": "article-29964_34", "title": "Testicular Teratoma -- Treatment / Management", "content": "Stage I tumors are treated depending on the lymphovascular invasion (LVI) of the spermatic cord, infiltration of the scrotum, and serum markers. Orchiectomy is the treatment of choice, and the patient is then sent to surveillance or retroperitoneal lymph node dissection (RPLND). The latter is the choice in cases with transformed teratoma and cases where radiology cannot exclude a lymph node involvement. Viable GCT may be found in as much as 20% of primary RPLND done for pure testicular teratoma and usually implies either a small volume NSGCT which was missed in the pathological report of the orchiectomy specimen) or regressed viable GCT elements in the testis. Patients who choose surveillance should adhere to a strict follow-up aimed to detect early metastases. In patients choosing preventive chemotherapy, accurate staging with a CT-scan and a single cycle of bleomycin, etoposide, and cisplatin (BEP) is recommended.", "contents": "Testicular Teratoma -- Treatment / Management. Stage I tumors are treated depending on the lymphovascular invasion (LVI) of the spermatic cord, infiltration of the scrotum, and serum markers. Orchiectomy is the treatment of choice, and the patient is then sent to surveillance or retroperitoneal lymph node dissection (RPLND). The latter is the choice in cases with transformed teratoma and cases where radiology cannot exclude a lymph node involvement. Viable GCT may be found in as much as 20% of primary RPLND done for pure testicular teratoma and usually implies either a small volume NSGCT which was missed in the pathological report of the orchiectomy specimen) or regressed viable GCT elements in the testis. Patients who choose surveillance should adhere to a strict follow-up aimed to detect early metastases. In patients choosing preventive chemotherapy, accurate staging with a CT-scan and a single cycle of bleomycin, etoposide, and cisplatin (BEP) is recommended."}
{"id": "article-29964_35", "title": "Testicular Teratoma -- Treatment / Management", "content": "Stage I patients with positive nodes after RPLND are candidates for surveillance or adjuvant chemotherapy (suggested in pN2 cases, mandatory for pN3) with two cycles of etoposide+cisplatin (EP). Teratoma is not highly sensitive to chemotherapy, so it is not always recommended.", "contents": "Testicular Teratoma -- Treatment / Management. Stage I patients with positive nodes after RPLND are candidates for surveillance or adjuvant chemotherapy (suggested in pN2 cases, mandatory for pN3) with two cycles of etoposide+cisplatin (EP). Teratoma is not highly sensitive to chemotherapy, so it is not always recommended."}
{"id": "article-29964_36", "title": "Testicular Teratoma -- Treatment / Management", "content": "Patients in stage II present with regional lymphatic metastasis (retroperitoneum)\u00a0without other metastasis (any T, N1\u20133, M0, SX). Stage IIA is a clinical or pathological stage N1, less\u00a0than 2 cm; serum tumor markers are at normal levels or only slightly high (S1). In stage IIB, the\u00a0largest lymph node mass is between 2 and 5 cm in size (N2),\u00a0serum tumor markers are at normal levels or only slightly high (S1).\u00a0In stage IIC, there is at least one lymph node metastasis larger than 5 cm (N3). Stage II disease should be treated with chemotherapy if serum markers are elevated [indicates mixed histology]or if lymph nodes are enlarged (>3 cm).", "contents": "Testicular Teratoma -- Treatment / Management. Patients in stage II present with regional lymphatic metastasis (retroperitoneum)\u00a0without other metastasis (any T, N1\u20133, M0, SX). Stage IIA is a clinical or pathological stage N1, less\u00a0than 2 cm; serum tumor markers are at normal levels or only slightly high (S1). In stage IIB, the\u00a0largest lymph node mass is between 2 and 5 cm in size (N2),\u00a0serum tumor markers are at normal levels or only slightly high (S1).\u00a0In stage IIC, there is at least one lymph node metastasis larger than 5 cm (N3). Stage II disease should be treated with chemotherapy if serum markers are elevated [indicates mixed histology]or if lymph nodes are enlarged (>3 cm)."}
{"id": "article-29964_37", "title": "Testicular Teratoma -- Treatment / Management", "content": "Patients with incomplete resection (residual masses) should undergo\u00a0RPLND in lesions containing mainly teratoma. In cases of infiltration of the inferior vena cava wall or thrombi, these should be completely resected. The resection needs to be as complete as possible because teratomas tend to have a\u00a0local growth raising their risk of malignant transformation and relapse. Residual masses are usually chemoresistant, and\u00a0they progress despite chemotherapy.", "contents": "Testicular Teratoma -- Treatment / Management. Patients with incomplete resection (residual masses) should undergo\u00a0RPLND in lesions containing mainly teratoma. In cases of infiltration of the inferior vena cava wall or thrombi, these should be completely resected. The resection needs to be as complete as possible because teratomas tend to have a\u00a0local growth raising their risk of malignant transformation and relapse. Residual masses are usually chemoresistant, and\u00a0they progress despite chemotherapy."}
{"id": "article-29964_38", "title": "Testicular Teratoma -- Differential Diagnosis", "content": "Testicular teratoma should be differentiated from: Other testicular germ cell tumors Epidermoid cyst Testicular metastases from other tumors Lymphoma Testicular torsion Inguinal hernia Testicular abscess", "contents": "Testicular Teratoma -- Differential Diagnosis. Testicular teratoma should be differentiated from: Other testicular germ cell tumors Epidermoid cyst Testicular metastases from other tumors Lymphoma Testicular torsion Inguinal hernia Testicular abscess"}
{"id": "article-29964_39", "title": "Testicular Teratoma -- Radiation Oncology", "content": "Radiotherapy has practically no role in the management of testicular teratoma. It is primarily used as an adjuvant treatment if seminoma histology is present.", "contents": "Testicular Teratoma -- Radiation Oncology. Radiotherapy has practically no role in the management of testicular teratoma. It is primarily used as an adjuvant treatment if seminoma histology is present."}
{"id": "article-29964_40", "title": "Testicular Teratoma -- Treatment Planning -- BEP (5-day schedule)", "content": "Bleomycin 30 mg IV bolus day 1, 8, 15 or day 2, 9, 16 Etoposide 100 mg/m2/day IV daily Cisplatin 20 mg/m2/day IV\u00a0daily", "contents": "Testicular Teratoma -- Treatment Planning -- BEP (5-day schedule). Bleomycin 30 mg IV bolus day 1, 8, 15 or day 2, 9, 16 Etoposide 100 mg/m2/day IV daily Cisplatin 20 mg/m2/day IV\u00a0daily"}
{"id": "article-29964_41", "title": "Testicular Teratoma -- Treatment Planning -- EP\u00a0(5-day schedule)", "content": "Etoposide 100 mg/m2/day IV daily Cisplatin 20 mg/m2/day IV daily", "contents": "Testicular Teratoma -- Treatment Planning -- EP\u00a0(5-day schedule). Etoposide 100 mg/m2/day IV daily Cisplatin 20 mg/m2/day IV daily"}
{"id": "article-29964_42", "title": "Testicular Teratoma -- Toxicity and Adverse Effect Management", "content": "Sperm banking should be discussed with patients of reproductive age. Therapies for testicular teratoma include surgery, radiation therapy, and chemotherapy, so fertility counseling should be initiated before treatment.", "contents": "Testicular Teratoma -- Toxicity and Adverse Effect Management. Sperm banking should be discussed with patients of reproductive age. Therapies for testicular teratoma include surgery, radiation therapy, and chemotherapy, so fertility counseling should be initiated before treatment."}
{"id": "article-29964_43", "title": "Testicular Teratoma -- Medical Oncology", "content": "Teratoma, a histologic subtype of nonseminoma that represents terminally differentiated somatic tissue, is chemotherapy-resistant. When in the pure form, it is not associated with tumor marker production or FDG-avidity.However, about two-thirds of NSGCTs[including pure testicular teratomas]may present with advanced metastatic disease. This is generally due to the so-called \"burnt out testicular NSGCT\" and can present with elevated tumor markers and viable GCT (embryonal cell carcinoma or yolk sac tumor) in metastatic lesions. The patients would be managed initially with chemotherapy as per IGCCCG risk stratification followed by post-chemo RPLND. The final retroperitoneal specimen usually reveals fibrosis (44%) or teratoma (50%), or viable GCT (6%). The clinician might also encounter a poor response to induction chemotherapy in advanced NSGCT cases if teratomatous elements are present in the orchiectomy specimen.", "contents": "Testicular Teratoma -- Medical Oncology. Teratoma, a histologic subtype of nonseminoma that represents terminally differentiated somatic tissue, is chemotherapy-resistant. When in the pure form, it is not associated with tumor marker production or FDG-avidity.However, about two-thirds of NSGCTs[including pure testicular teratomas]may present with advanced metastatic disease. This is generally due to the so-called \"burnt out testicular NSGCT\" and can present with elevated tumor markers and viable GCT (embryonal cell carcinoma or yolk sac tumor) in metastatic lesions. The patients would be managed initially with chemotherapy as per IGCCCG risk stratification followed by post-chemo RPLND. The final retroperitoneal specimen usually reveals fibrosis (44%) or teratoma (50%), or viable GCT (6%). The clinician might also encounter a poor response to induction chemotherapy in advanced NSGCT cases if teratomatous elements are present in the orchiectomy specimen."}
{"id": "article-29964_44", "title": "Testicular Teratoma -- Staging", "content": "To accurately stage the disease, it must be searched for metastatic or occult disease. Useful tools are serum tumor markers, CT scan, or MRI to screen for\u00a0nodal pathway and visceral metastases.\u00a0Metastases from mature and immature teratoma have been reported at initial presentation in 13% to 60% of cases. [25]", "contents": "Testicular Teratoma -- Staging. To accurately stage the disease, it must be searched for metastatic or occult disease. Useful tools are serum tumor markers, CT scan, or MRI to screen for\u00a0nodal pathway and visceral metastases.\u00a0Metastases from mature and immature teratoma have been reported at initial presentation in 13% to 60% of cases. [25]"}
{"id": "article-29964_45", "title": "Testicular Teratoma -- Staging", "content": "The AJCC's 8th edition of a TNM staging system is the international gold standard. It uses T (tumor primary), N (node involvement), M (metastases) for pathological and radiological staging, plus S (serum markers), which is a unique parameter of testicular cancer.", "contents": "Testicular Teratoma -- Staging. The AJCC's 8th edition of a TNM staging system is the international gold standard. It uses T (tumor primary), N (node involvement), M (metastases) for pathological and radiological staging, plus S (serum markers), which is a unique parameter of testicular cancer."}
{"id": "article-29964_46", "title": "Testicular Teratoma -- Prognosis", "content": "The International Germ Cell Cancer Collaborative Group (IGCCCG)\u00a0is the\u00a0reference classification for assessing prognosis in patients with advanced non-seminomatous germ-cell tumors. Three risk classes are identified, as shown in the following table.", "contents": "Testicular Teratoma -- Prognosis. The International Germ Cell Cancer Collaborative Group (IGCCCG)\u00a0is the\u00a0reference classification for assessing prognosis in patients with advanced non-seminomatous germ-cell tumors. Three risk classes are identified, as shown in the following table."}
{"id": "article-29964_47", "title": "Testicular Teratoma -- Prognosis", "content": "Postpubertal-type teratomas have a less benign prognosis. Adults with pure mature teratoma have\u00a0metastases in over 40%,\u00a0but the overall survival is close to 100% after 5-year when the disease is localized.In metastatic somatic-type malignancies, patients do not respond well to conventional\u00a0chemotherapy used for metastatic germ cell tumors, so that the overall survival drops.Teratoma,\u00a0even the mature form, has an unpredictable behavior,\u00a0being locally-invasive and bearing the possibility of malignant\u00a0transformation into somatic tumors such as sarcoma (commonest type, especially rhabdomyosarcoma) or carcinoma. The presence of teratoma is associated with a higher cumulative incidence of disease-related death. [11]", "contents": "Testicular Teratoma -- Prognosis. Postpubertal-type teratomas have a less benign prognosis. Adults with pure mature teratoma have\u00a0metastases in over 40%,\u00a0but the overall survival is close to 100% after 5-year when the disease is localized.In metastatic somatic-type malignancies, patients do not respond well to conventional\u00a0chemotherapy used for metastatic germ cell tumors, so that the overall survival drops.Teratoma,\u00a0even the mature form, has an unpredictable behavior,\u00a0being locally-invasive and bearing the possibility of malignant\u00a0transformation into somatic tumors such as sarcoma (commonest type, especially rhabdomyosarcoma) or carcinoma. The presence of teratoma is associated with a higher cumulative incidence of disease-related death. [11]"}
{"id": "article-29964_48", "title": "Testicular Teratoma -- Complications", "content": "Orchiectomy procedure coupled with lymph node dissection has major morbidity of retrograde ejaculation, so a nerve-sparing resection is recommended whenever applicable (stage I disease with normal serum markers).", "contents": "Testicular Teratoma -- Complications. Orchiectomy procedure coupled with lymph node dissection has major morbidity of retrograde ejaculation, so a nerve-sparing resection is recommended whenever applicable (stage I disease with normal serum markers)."}
{"id": "article-29964_49", "title": "Testicular Teratoma -- Deterrence and Patient Education", "content": "Since the US Preventive Services Task Force recommends against\u00a0a population screening for testicular cancer, patients at high risk of testicular cancer must be identified and educated regarding their specific risk, explaining the most common signs and symptoms of testicular teratoma. Even though no specific data recommends a self-examination, high-risk patients can be trained to perform a regular palpatory exam and consult with a clinician in doubtful cases. This method could increase mass detection and decrease ultrasound examinations as a screening method. Finally, education and reassurance\u00a0in high-risk men and patients with known testicular cancer contribute to\u00a0eliminating\u00a0patient-doctor barriers and improving communication.", "contents": "Testicular Teratoma -- Deterrence and Patient Education. Since the US Preventive Services Task Force recommends against\u00a0a population screening for testicular cancer, patients at high risk of testicular cancer must be identified and educated regarding their specific risk, explaining the most common signs and symptoms of testicular teratoma. Even though no specific data recommends a self-examination, high-risk patients can be trained to perform a regular palpatory exam and consult with a clinician in doubtful cases. This method could increase mass detection and decrease ultrasound examinations as a screening method. Finally, education and reassurance\u00a0in high-risk men and patients with known testicular cancer contribute to\u00a0eliminating\u00a0patient-doctor barriers and improving communication."}
{"id": "article-29964_50", "title": "Testicular Teratoma -- Enhancing Healthcare Team Outcomes", "content": "Interprofessional communication between a primary care physician, urologists, radiologists, pathologists, oncologists, pharmacists, nurses, and laboratory personnel is necessary for professionals to effectively treat testicular teratoma. Patients with increased risk for developing testicular cancer, including positive family history, cryptorchidism, and testicular atrophy, should be informed and trained accordingly. Primary care physicians hold clinical information and the family history of the patient. Therefore they should provide all significant information to carefully identify the high-risk patient, reassure and counsel the patient during all the course of the disease, and schedule checkups. Continuous support must entail not only from the medical staff but also from close family members and friends.", "contents": "Testicular Teratoma -- Enhancing Healthcare Team Outcomes. Interprofessional communication between a primary care physician, urologists, radiologists, pathologists, oncologists, pharmacists, nurses, and laboratory personnel is necessary for professionals to effectively treat testicular teratoma. Patients with increased risk for developing testicular cancer, including positive family history, cryptorchidism, and testicular atrophy, should be informed and trained accordingly. Primary care physicians hold clinical information and the family history of the patient. Therefore they should provide all significant information to carefully identify the high-risk patient, reassure and counsel the patient during all the course of the disease, and schedule checkups. Continuous support must entail not only from the medical staff but also from close family members and friends."}
{"id": "article-29964_51", "title": "Testicular Teratoma -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Testicular Teratoma -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}